16 results
SC14D9C
EX-2.1
CTIC
CTI BioPharma Corp
10 May 23
Written communication relating to third party tender offer
1:30pm
8-K
EX-2.1
CTIC
CTI BioPharma Corp
10 May 23
Tender and Support Agreement
8:05am
S-8
EX-5.1
CTIC
CTI BioPharma Corp
19 Jun 20
Registration of securities for employees
4:27pm
8-K
EX-99.1
CTIC
CTI BioPharma Corp
9 Mar 20
Other Events
12:00am
8-K
EX-99.1
CTIC
CTI BioPharma Corp
3 Feb 20
Entry into a Material Definitive Agreement
6:09am
8-K
EX-2.1
lai3 9iic
24 Jan 18
Entry into a Material Definitive Agreement
12:00am
8-K/A
EX-2.1
1t1fcuxjaiyajeb41r
6 Nov 14
Financial Statements and Exhibits
12:00am
8-K
EX-2.1
3dab3sm
19 Dec 08
Entry into a Material Definitive Agreement
12:00am
8-K
EX-2.1
kvbec4nxxfv0e
27 Jul 07
Cell Therapeutics, Inc. (CTI) Announces Agreement to Acquire SMi; Gains Global Rights to Brostallicin, in a New Class of Cancer Killing Agents
12:00am
8-K
EX-2.4
27kl68w
17 Jun 03
Cell Therapeutics, Inc. (CTI) Adds Pixantrone to its Oncology
12:00am
8-K
EX-2.2
a145 1zbf
17 Jun 03
Cell Therapeutics, Inc. (CTI) Adds Pixantrone to its Oncology
12:00am
8-K
EX-2.5
pr8mt1 ndl
17 Jun 03
Cell Therapeutics, Inc. (CTI) Adds Pixantrone to its Oncology
12:00am
8-K
EX-2.1
92hr50b
17 Jun 03
Cell Therapeutics, Inc. (CTI) Adds Pixantrone to its Oncology
12:00am
8-K
EX-2.3
9m0qq
17 Jun 03
Cell Therapeutics, Inc. (CTI) Adds Pixantrone to its Oncology
12:00am
8-K
EX-2.1
gudmj9jhjw4eucg2o2
25 Jan 00
Cell Therapeutics, Inc. - Form 8-K
12:00am
- Prev
- 1
- Next